BeOne Medicines (ONC) Net Cash Flow (2015 - 2026)
BeOne Medicines (ONC) reported Net Cash Flow of $224.5 million for Q1 2026, up 301.06% year-over-year from $56.0 million in Q1 2025, and down 52.84% on a QoQ basis from $475.9 million in Q4 2025.
BeOne Medicines (ONC) has 12 years of Net Cash Flow data on file, last reported at $224.5 million in Q1 2026.
- Quarterly Net Cash Flow rose 301.06% year-over-year to $224.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 billion (up 995.0% YoY) and the FY2025 annual result came in at $1.9 billion, up 485.62% from the prior year.
- Net Cash Flow eased to $224.5 million in Q1 2026 per ONC's latest filing, from $475.9 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $1.3 billion in Q3 2025 and bottomed at -$390.0 million in Q4 2022.
- The 5-year median for Net Cash Flow is -$37.4 million (2022), against an average of $30.6 million.
- The widest annual swing landed in 2023, when Net Cash Flow tumbled 815.09%; it then soared 2172.2% in 2025.
- Tracing ONC's Net Cash Flow over 5 years: stood at -$390.0 million in 2022, then soared by 116.11% to $62.8 million in 2023, then slumped by 136.56% to -$23.0 million in 2024, then soared by 2172.2% to $475.9 million in 2025, then plunged by 52.84% to $224.5 million in 2026.
- Per Business Quant, the three latest ONC Net Cash Flow figures stand at $224.5 million (Q1 2026), $475.9 million (Q4 2025), and $1.3 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -152.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 60.68 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 224.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 224.46 Mn |
| Mar 31, 2026 | 224.46 Mn |
| Dec 31, 2025 | 475.94 Mn |
| Dec 31, 2025 | 475.94 Mn |
| Sep 30, 2025 | 1.31 Bn |
| Sep 30, 2025 | 1.31 Bn |
| Jun 30, 2025 | 232.02 Mn |
| Jun 30, 2025 | 232.02 Mn |
| Mar 31, 2025 | -111.64 Mn |
| Mar 31, 2025 | -111.64 Mn |
| Dec 31, 2024 | -22.97 Mn |
| Dec 31, 2024 | -22.97 Mn |
| Sep 30, 2024 | 67.15 Mn |
| Sep 30, 2024 | 67.15 Mn |
| Jun 30, 2024 | -183.60 Mn |
| Jun 30, 2024 | -183.60 Mn |
| Mar 31, 2024 | -356.11 Mn |
| Mar 31, 2024 | -356.11 Mn |
| Dec 31, 2023 | 62.83 Mn |
| Dec 31, 2023 | 62.83 Mn |
| Sep 30, 2023 | -341.21 Mn |
| Sep 30, 2023 | -341.21 Mn |
| Jun 30, 2023 | -60.01 Mn |
| Jun 30, 2023 | -60.01 Mn |
| Mar 31, 2023 | -342.58 Mn |
| Mar 31, 2023 | -342.58 Mn |
| Dec 31, 2022 | -390.02 Mn |
| Dec 31, 2022 | -390.02 Mn |
| Sep 30, 2022 | -272.18 Mn |
| Sep 30, 2022 | -272.18 Mn |
| Jun 30, 2022 | 261.17 Mn |
| Jun 30, 2022 | 261.17 Mn |
| Mar 31, 2022 | -37.44 Mn |
| Mar 31, 2022 | -37.44 Mn |
| Dec 31, 2021 | 3.39 Bn |
| Dec 31, 2021 | 3.39 Bn |
| Sep 30, 2021 | -398.50 Mn |
| Sep 30, 2021 | -398.50 Mn |
| Jun 30, 2021 | -133.04 Mn |
| Jun 30, 2021 | -133.04 Mn |
| Mar 31, 2021 | 524.46 Mn |
| Mar 31, 2021 | 524.46 Mn |
| Dec 31, 2020 | -93.60 Mn |
| Dec 31, 2020 | -93.60 Mn |
| Sep 30, 2020 | 111.19 Mn |
| Sep 30, 2020 | 111.19 Mn |
| Jun 30, 2020 | -611.84 Mn |
| Jun 30, 2020 | -611.84 Mn |
| Mar 31, 2020 | 1.35 Bn |
| Mar 31, 2020 | 1.35 Bn |
| Dec 31, 2019 | -288.88 Mn |
| Dec 31, 2019 | -288.88 Mn |
| Sep 30, 2019 | -26.25 Mn |
| Sep 30, 2019 | -26.25 Mn |
| Jun 30, 2019 | 161.29 Mn |
| Jun 30, 2019 | 161.29 Mn |
| Mar 31, 2019 | 43.41 Mn |
| Mar 31, 2019 | 43.41 Mn |
| Dec 31, 2018 | 28.15 Mn |
| Dec 31, 2018 | 28.15 Mn |
| Sep 30, 2018 | 248.43 Mn |
| Sep 30, 2018 | 248.43 Mn |
| Jun 30, 2018 | -36.42 Mn |
| Jun 30, 2018 | -36.42 Mn |
| Mar 31, 2018 | 265.05 Mn |
| Mar 31, 2018 | 265.05 Mn |
| Dec 31, 2017 | 28.56 Mn |
| Dec 31, 2017 | 28.56 Mn |
| Sep 30, 2017 | -55.02 Mn |
| Sep 30, 2017 | -55.02 Mn |
| Jun 30, 2017 | 162.89 Mn |
| Jun 30, 2017 | 162.89 Mn |
| Mar 31, 2017 | 10.37 Mn |
| Mar 31, 2017 | 10.37 Mn |
| Dec 31, 2016 | 1.83 Mn |
| Dec 31, 2016 | 1.83 Mn |
| Sep 30, 2016 | 27.44 Mn |
| Sep 30, 2016 | 27.44 Mn |
| Jun 30, 2016 | -150.28 Mn |
| Jun 30, 2016 | -150.28 Mn |
| Mar 31, 2016 | 190.55 Mn |
| Mar 31, 2016 | 190.55 Mn |
| Dec 31, 2015 | -9.58 Mn |
| Dec 31, 2015 | -9.58 Mn |
| Sep 30, 2015 | 2.75 Mn |
| Sep 30, 2015 | 2.75 Mn |
| Jun 30, 2015 | -85.18 Mn |
| Jun 30, 2015 | -85.18 Mn |
| Mar 31, 2015 | -480,000.00 |
| Mar 31, 2015 | -480,000.00 |